1
October 2024
Argent BioPharma
Ltd.
(Argent BioPharma or the Company)
Results of Shareholder's
General Meeting
Argent BioPharma is pleased to
announce the voting results from the Company's General Meeting of
Shareholders held today, Tuesday, 1 October 2024.
The Company confirms that all
motions put to the meeting were voted by poll, with all resolutions
carried.
Details of the results can be found
in the following URL:
https://www.investi.com.au/api/announcements/rgt/4ae25edd-f7d.pdf
Additionally, the Company advises
that it is actively progressing towards the appointment of a
sponsor, a key step in moving its listing category from Equity
Shares (International Commercial Companies - Secondary Listing) to
Equity Shares (Commercial Companies) category (ESCC) of the
FCA's Official List. Following the appointment of a sponsor, the
Company will be in a position to submit an application to the
Financial Conduct Authority (FCA) to facilitate the move between
listing categories. Once this process is complete, the Company will
provide an updated indicative timetable outlining the anticipated
ASX delisting timeline, in accordance with the approval granted by
shareholders at the General Meeting held today.
There can be no guarantee whether or
when an Application to transfer listing category will be approved,
notwithstanding the shareholder approval granted today. The Company
will not delist from the ASX without such approval of the
Application to transfer to the ESCC.
-Ends-
Authorised for release by the Company Secretary, for further
information please contact:
About Argent
BioPharma
Argent BioPharma Limited (the
Company) (ASX: RGT; LSE:
RGT; OTCQB: RGTLF) an innovative multidisciplinary drug development
Company within the biopharmaceutical sector. The Company
focuses on multidisciplinary methods with Nanotechnology,
developing multi-target therapies for comprehensive disease
management, especially concerning the Central nervous system
(CNS) and Immunology
treatments.
Follow us through our social media
channels:
LinkedIn: Argent
BioPharma
Twitter: @ArgentBioPharma
Facebook: Argent BioPharma